Medical University of South Carolina

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1955-01-01

Employees: 10K

Market Cap: -

Website: https://www.muschealth.com

Clinical Trials

Open Label Trial of Acamprosate in Bipolar Alcoholics

Phase 1

Completed

Conditions: Alcohol Dependence
Bipolar Disorder

First Posted Date: 2006-05-26

Last Posted Date: 2008-09-19

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 9

Registration Number: NCT00330486

Locations: 🇺🇸
Institute of Psychiatry, Medical University of South Carolina, Charleston, South Carolina, United States

Acamprosate in Alcoholics With Comorbid Anxiety or Depression

Phase 4

Completed

Conditions: Generalized Anxiety Disorder
Alcohol Dependence
Major Depression
Social Anxiety Disorder

Interventions: Drug: Acamprosate

First Posted Date: 2006-05-26

Last Posted Date: 2015-04-13

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 90

Registration Number: NCT00330174

Locations: 🇺🇸
Columbia University College of Physicians & Surgeons, New York, New York, United States
🇺🇸
Behavioral Health Services of Pickens County, Pickens, South Carolina, United States
🇺🇸
McLean Hospital, Belmont, Massachusetts, United States

Evaluation of Vitamin D Requirements During Pregnancy

Phase 3

Completed

Conditions: Vitamin D Deficiency

Interventions: Drug: cholecalciferol (vitamin D3)
Drug: cholecalciferol

First Posted Date: 2006-02-16

Last Posted Date: 2016-09-19

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 501

Registration Number: NCT00292591

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

Bortezomib and Celecoxib in Treating Patients With Advanced Solid Tumors

Phase 1

Completed

Conditions: Unspecified Adult Solid Tumor, Protocol Specific

First Posted Date: 2006-02-13

Last Posted Date: 2018-04-10

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 36

Registration Number: NCT00290680

Locations: 🇺🇸
Hollings Cancer Center at Medical University of South Carolina, Charleston, South Carolina, United States

Topotecan and Vinorelbine in Treating Patients With Recurrent Lung Cancer

Phase 1

Completed

Conditions: Lung Cancer

Interventions: Drug: topotecan hydrochloride
Drug: vinorelbine tartrate

First Posted Date: 2006-02-07

Last Posted Date: 2018-05-17

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 18

Registration Number: NCT00287963

Locations: 🇺🇸
Hollings Cancer Center at Medical University of South Carolina, Charleston, South Carolina, United States

The Effect of Contrast Media on Erythrocytes in Healthy Volunteers

Completed

Conditions: Healthy Volunteers

First Posted Date: 2006-02-02

Last Posted Date: 2006-05-29

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 20

Registration Number: NCT00285506

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

Cisplatin, Bevacizumab, and Gemcitabine Followed by Surgery, Bevacizumab, and Paclitaxel in Treating Patients With Locally Advanced Nonmetastatic Bladder Cancer That Can Be Removed By Surgery

Phase 2

Terminated

Conditions: Bladder Cancer

Interventions: Biological: bevacizumab
Drug: cisplatin
Drug: gemcitabine hydrochloride
Drug: paclitaxel
Procedure: cysectomy

First Posted Date: 2005-12-22

Last Posted Date: 2018-07-12

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 21

Registration Number: NCT00268450

Locations: 🇺🇸
Gibbs Regional Cancer Center at Spartanburg Regional Medical Center, Spartanburg, South Carolina, United States
🇺🇸
Hollings Cancer Center at Medical University of South Carolina, Charleston, South Carolina, United States
🇺🇸
McLeod Regional Medical Center, Florence, South Carolina, United States

and more 1 locations

Prometa Protocol for Alcohol Dependence

Phase 2

Completed

Conditions: Alcohol Dependence

Interventions: Drug: Flumazenil and Gabapentin
Drug: Placebo

First Posted Date: 2005-12-07

Last Posted Date: 2019-02-15

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 60

Registration Number: NCT00262639

Locations: 🇺🇸
MUSC-Center for Drug and Alcohol Programs, Charleston, South Carolina, United States

Mycophenolate for Pulmonary Sarcoidosis

Phase 3

Terminated

Conditions: Pulmonary Sarcoidosis

First Posted Date: 2005-12-06

Last Posted Date: 2018-06-18

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 20

Registration Number: NCT00262132

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

Safety and Efficacy of Alendronate (Fosamax) in Children With Osteoporosis

Phase 2

Completed

Conditions: Osteoporosis

Interventions: Drug: Alendronate

First Posted Date: 2005-12-01

Last Posted Date: 2011-01-19

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 22

Registration Number: NCT00259857

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy